The Nlrp3 inflammasome: contributions to intestinal homeostasis

Cho, 2008, The genetics and immunopathogenesis of inflammatory bowel disease, Nat. Rev. Immunol., 8, 458, 10.1038/nri2340

Fiocchi, 1998, Inflammatory bowel disease: etiology and pathogenesis, Gastroenterology, 115, 182, 10.1016/S0016-5085(98)70381-6

Goyette, 2007, Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine, Ann. Med., 39, 177, 10.1080/07853890701197615

Kanneganti, 2007, Intracellular NOD-like receptors in host defense and disease, Immunity, 27, 549, 10.1016/j.immuni.2007.10.002

Kaser, 2010, Inflammatory bowel disease, Annu. Rev. Immunol., 28, 573, 10.1146/annurev-immunol-030409-101225

Villani, 2009, Common variants in the NLRP3 region contribute to Crohn's disease susceptibility, Nat. Genet., 41, 71, 10.1038/ng.285

Kanneganti, 2006, Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3, Nature, 440, 233, 10.1038/nature04517

Mariathasan, 2006, Cryopyrin activates the inflammasome in response to toxins and ATP, Nature, 440, 228, 10.1038/nature04515

Sutterwala, 2006, Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1, Immunity, 24, 317, 10.1016/j.immuni.2006.02.004

Dinarello, 2009, Immunological and inflammatory functions of the interleukin-1 family, Annu. Rev. Immunol., 27, 519, 10.1146/annurev.immunol.021908.132612

Sivakumar, 2002, Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage, Gut, 50, 812, 10.1136/gut.50.6.812

Siegmund, 2001, Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production, Am. J. Physiol. Regul. Integr. Comp. Physiol., 281, R1264, 10.1152/ajpregu.2001.281.4.R1264

Siegmund, 2002, Interleukin-1beta converting enzyme (caspase-1) in intestinal inflammation, Biochem. Pharmacol., 64, 1, 10.1016/S0006-2952(02)01064-X

Bauer, 2007, The ICE inhibitor pralnacasan prevents DSS-induced colitis in C57BL/6 mice and suppresses IP-10 mRNA but not TNF-alpha mRNA expression, Dig. Dis. Sci., 52, 1642, 10.1007/s10620-007-9802-8

Allen, 2010, The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer, J. Exp. Med., 207, 1045, 10.1084/jem.20100050

Dupaul-Chicoine, 2010, Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases, Immunity, 32, 367, 10.1016/j.immuni.2010.02.012

Hirota, 2010, NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis, Inflamm. Bowel Dis.

Zaki, 2010, The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis, Immunity, 32, 379, 10.1016/j.immuni.2010.03.003

Zaki, 2010, IL-18 Production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation, J. Immunol., 185, 4912, 10.4049/jimmunol.1002046

Hugot, 2001, Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease, Nature, 411, 599, 10.1038/35079107

Rioux, 2005, Paths to understanding the genetic basis of autoimmune disease, Nature, 435, 584, 10.1038/nature03723

McGovern, 2005, Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease, Hum. Mol. Genet., 14, 1245, 10.1093/hmg/ddi135

Travassos, 2010, Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry, Nat. Immunol., 11, 55, 10.1038/ni.1823

Rioux, 2007, Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis, Nat. Genet., 39, 596, 10.1038/ng2032

Hampe, 2007, A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1, Nat. Genet., 39, 207, 10.1038/ng1954

Hoffman, 2001, Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome, Nat. Genet., 29, 301, 10.1038/ng756

Feldmann, 2002, Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes, Am. J. Hum. Genet., 71, 198, 10.1086/341357

Lamkanfi, 2010, Nlrp3: an immune sensor of cellular stress and infection, Int. J. Biochem. Cell Biol., 42, 792, 10.1016/j.biocel.2010.01.008

Martinon, 2004, Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome, Curr. Biol., 14, 1929, 10.1016/j.cub.2004.10.027

Lamkanfi, 2009, The inflammasomes, PLoS Pathog., 5, e1000510, 10.1371/journal.ppat.1000510

Kanneganti, 2006, Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA, J. Biol. Chem., 281, 36560, 10.1074/jbc.M607594200

Muruve, 2008, The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response, Nature, 452, 103, 10.1038/nature06664

Thomas, 2009, The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1, Immunity, 30, 566, 10.1016/j.immuni.2009.02.006

Ichinohe, 2009, Inflammasome recognition of influenza virus is essential for adaptive immune responses, J. Exp. Med., 206, 79, 10.1084/jem.20081667

Allen, 2009, The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA, Immunity, 30, 556, 10.1016/j.immuni.2009.02.005

Gross, 2009, Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence, Nature, 459, 433, 10.1038/nature07965

Hise, 2009, An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans, Cell Host Microbe, 5, 487, 10.1016/j.chom.2009.05.002

Joly, 2009, Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome, J. Immunol., 183, 3578, 10.4049/jimmunol.0901323

Feldmeyer, 2007, The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes, Curr. Biol., 17, 1140, 10.1016/j.cub.2007.05.074

Eisenbarth, 2008, Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants, Nature, 453, 1122, 10.1038/nature06939

Li, 2008, Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3, J. Immunol., 181, 17, 10.4049/jimmunol.181.1.17

Franchi, 2008, The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity, Eur. J. Immunol., 38, 2085, 10.1002/eji.200838549

McKee, 2009, Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity, J. Immunol., 183, 4403, 10.4049/jimmunol.0900164

van Heel, 2005, Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease, Lancet, 365, 1794, 10.1016/S0140-6736(05)66582-8

Li, 2004, Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations, Hum. Mol. Genet., 13, 1715, 10.1093/hmg/ddh182

van Beelen, 2007, Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells, Immunity, 27, 660, 10.1016/j.immuni.2007.08.013

Tamura, 2002, IL18 polymorphism is associated with an increased risk of Crohn's disease, J. Gastroenterol., 37, 111, 10.1007/BF03326428

Zhernakova, 2008, Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP, Am. J. Hum. Genet., 82, 1202, 10.1016/j.ajhg.2008.03.016

Pizarro, 1999, IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells, J. Immunol., 162, 6829, 10.4049/jimmunol.162.11.6829

Monteleone, 1999, Bioactive IL-18 expression is up-regulated in Crohn's disease, J. Immunol., 163, 143, 10.4049/jimmunol.163.1.143

Papadakis, 2000, Role of cytokines in the pathogenesis of inflammatory bowel disease, Annu. Rev. Med., 51, 289, 10.1146/annurev.med.51.1.289

Pizarro, 2003, Mouse models for the study of Crohn's disease, Trends Mol. Med., 9, 218, 10.1016/S1471-4914(03)00052-2

Kitajima, 1999, Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium, Exp. Anim., 48, 137, 10.1538/expanim.48.137

Rakoff-Nahoum, 2004, Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis, Cell, 118, 229, 10.1016/j.cell.2004.07.002

Radtke, 2005, Self-renewal and cancer of the gut: two sides of a coin, Science, 307, 1904, 10.1126/science.1104815

Dupaul-Chicoine, 2010, Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases, Immunity, 32, 367, 10.1016/j.immuni.2010.02.012

Simms, 2008, Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease, Gut, 57, 903, 10.1136/gut.2007.142588

Wehkamp, 2004, NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression, Gut, 53, 1658, 10.1136/gut.2003.032805

Hu, 2010, Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4, Proc. Natl. Acad. Sci. U.S.A., 107, 21635, 10.1073/pnas.1016814108

Kummer, 2007, Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response, J. Histochem. Cytochem., 55, 443, 10.1369/jhc.6A7101.2006

Nenci, 2007, Epithelial NEMO links innate immunity to chronic intestinal inflammation, Nature, 446, 557, 10.1038/nature05698

Reuter, 2004, Commentary: the role of the IL-18 system and other members of the IL-1R/TLR superfamily in innate mucosal immunity and the pathogenesis of inflammatory bowel disease: friend or foe?, Eur. J. Immunol., 34, 2347, 10.1002/eji.200425351

Takagi, 2003, Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice, Scand. J. Gastroenterol., 38, 837, 10.1080/00365520310004047

Lebeis, 2009, Interleukin-1 receptor signaling protects mice from lethal intestinal damage caused by the attaching and effacing pathogen Citrobacter rodentium, Infect. Immun., 77, 604, 10.1128/IAI.00907-08

Araki, 2005, MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis, J. Gastroenterol., 40, 16, 10.1007/s00535-004-1492-9

Fukata, 2005, Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis, Am. J. Physiol. Gastrointest. Liver Physiol., 288, G1055, 10.1152/ajpgi.00328.2004

Siegmund, 2001, IL-1 beta -converting enzyme (caspase-1) in intestinal inflammation, Proc. Natl. Acad. Sci. U.S.A., 98, 13249, 10.1073/pnas.231473998

Loher, 2004, The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation, J. Pharmacol. Exp. Ther., 308, 583, 10.1124/jpet.103.057059

Bauer, 2010, Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome, Gut, 59, 1192, 10.1136/gut.2009.197822

Itzkowitz, 2004, Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation, Am. J. Physiol. Gastrointest. Liver Physiol., 287, G7, 10.1152/ajpgi.00079.2004

Chen, 2008, The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis, Cancer Res., 68, 10060, 10.1158/0008-5472.CAN-08-2061

Roberts, 2006, Caspase recruitment domain-containing protein 15 mutations in patients with colorectal cancer, Cancer Res., 66, 2532, 10.1158/0008-5472.CAN-05-4165

Micallef, 1997, Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma, Cancer Res., 57, 4557

Micallef, 1997, In vivo antitumor effects of murine interferon-gamma-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites, Cancer Immunol. Immunother., 43, 361, 10.1007/s002620050345

Osaki, 1999, Potent antitumor effects mediated by local expression of the mature form of the interferon-gamma inducing factor, interleukin-18 (IL-18), Gene Ther., 6, 808, 10.1038/sj.gt.3300908

Osaki, 1998, IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects, J. Immunol., 160, 1742, 10.4049/jimmunol.160.4.1742

Cao, 2007, T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface, Immunity, 26, 311, 10.1016/j.immuni.2007.01.016

Coughlin, 1998, Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis, J. Clin. Invest., 101, 1441, 10.1172/JCI1555

Hegardt, 2001, Nitric oxide synthase inhibitor and IL-18 enhance the anti-tumor immune response of rats carrying an intrahepatic colon carcinoma, Cancer Immunol. Immunother., 50, 491, 10.1007/s002620100230

Salcedo, 2010, MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18, J. Exp. Med., 207, 1625, 10.1084/jem.20100199

Nava, 2010, Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways, Immunity, 32, 392, 10.1016/j.immuni.2010.03.001

Kanai, 2001, Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease, Gastroenterology, 121, 875, 10.1053/gast.2001.28021

Nakamura, 2000, IFN-gamma-dependent and -independent mechanisms in adverse effects caused by concomitant administration of IL-18 and IL-12, J. Immunol., 164, 3330, 10.4049/jimmunol.164.6.3330

Ten Hove, 2001, Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice, Gastroenterology, 121, 1372, 10.1053/gast.2001.29579

Wirtz, 2002, Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA, J. Immunol., 168, 411, 10.4049/jimmunol.168.1.411

Siegmund, 2010, Interleukin-18 in intestinal inflammation: friend and foe?, Immunity, 32, 300, 10.1016/j.immuni.2010.03.010